A broadly based, multidisciplinary business sector which is subject to regulation in certain technical areas on a jurisdictional basis, and is impacted by a variety of factors at every level.
An overriding fundamental issue for the sector is how global food production can be intensified to feed a projected nine billion people by 2050, whilst dealing with impacts of climate change.
Improvements in efficiency and sustainability in agriculture continue to drive ingenious solutions that harness various cutting-edge technologies, such as genomics and CRISPR gene editing, big data, algorithms and AI. As such, inventions in this sector increasingly involve crossover technologies, requiring the pooling of expertise and effort amongst HGF’s life scientists, chemists and electronics and software attorneys.
Regulatory aspects govern many plant protection product inventions, and additional levels of IP protection can be available via Supplementary Protection Certificates (SPCs). There are also potential Convention on Biological Diversity and Nagoya Protocol constraints which can present particular R & D hurdles, and IP issues for inventions which use certain biological materials and their derivatives.
HGF has the corresponding necessarily specialised and multidisciplinary team of attorneys and lawyers for dealing with IP in this sector. The AgBio and Agritech team is comprised of technically and commercially experienced attorneys, including senior ex-Global 500 company attorneys who provide additional levels of commercial experience and acumen. Where IP issues are more legal rather than technical, our team adjusts to include or be led by solicitors who are highly experienced in contract negotiation, litigation or management level briefings on IP issues developing technology areas.
HGF’s attorneys deal with inventions in accelerated plant breeding procedures, genetically engineered or modified crops, actives and formulations for plant protection products, diagnostics, precision and digital agriculture, genetically engineered or modified animals, improved husbandry methods and carbon neutral systems.
Case study – alt fat innovation Many companies and investors are aware of the importance of identifying and protecting their innovations, and in particular of the importance of obtaining patents …Read article
HGF is a gold sponsor at the BioCap Conference 2022. The conference will be held on Thursday 22 September at the Alderley Park Conference Centre. It connects life sciences businesses, …Event details
Is the USPTO now stricter than the EPO on antibody claims? A consideration of recent developments from both sides of the pond. Patent protection for monoclonal antibodies, bispecific antibodies and …Read article
After a challenging couple of years, we are delighted to invite you to join us for HGF’s eighth annual IP in Healthcare Conference. We will review the latest intellectual property …Event details
HGF hosted a webinar on Wednesday 23rd March on Getting your first filing right. One of the most often asked questions of patent attorneys is: “when should we file?” Both …Event details
HGF Partner and Patent Attorney Craig Thomson and Patent Director Dr Jennifer Bailey write an article for The Microbiome Times on ELIGO v SNIPR: a reflection on IP strategies in …Read article
One of the most often asked questions of patent attorneys is “when should we file?” Both timing and content of a first filing should be important strategic decisions. This is …Read article
Using SleepCogni as a case study, we look at some key ways that IP can help start-ups to develop their technology and secure investment. SleepCogni is a SleepTech start-up who …Read article